BiochemistryBiomoleculesPeer-reviewed
Alirocumab attenuated plaque inflammation and PCSK9-induced proinflammatory signalling in M1 macrophages independently of lipid lowering
Cristina Espadas, Manuel Soto‐Catalán, M. Romero-Cote…·Oscar Lorenzo
This study shows alirocumab reduces plaque inflammation and PCSK9-induced proinflammatory signaling in M1 macrophages without affecting LDL-C levels.